925 related articles for article (PubMed ID: 11810038)
1. Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids.
Mystakidou K; Befon S; Tsilika E; Dardoufas K; Georgaki S; Vlahos L
Oncology; 2002; 62(1):9-16. PubMed ID: 11810038
[TBL] [Abstract][Full Text] [Related]
2. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
[TBL] [Abstract][Full Text] [Related]
3. A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain.
Sloan PA; Moulin DE; Hays H
J Pain Symptom Manage; 1998 Aug; 16(2):102-11. PubMed ID: 9737101
[TBL] [Abstract][Full Text] [Related]
4. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
[TBL] [Abstract][Full Text] [Related]
5. Initial dose cascade of TTS fentanyl with proper adjuvant medications in cancer pain.
Baik SW; Kim KH; Kim YC; Lee SC; Kim DK; Jung JE
J Korean Med Sci; 2003 Oct; 18(5):733-7. PubMed ID: 14555829
[TBL] [Abstract][Full Text] [Related]
6. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.
Jeal W; Benfield P
Drugs; 1997 Jan; 53(1):109-38. PubMed ID: 9010652
[TBL] [Abstract][Full Text] [Related]
7. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
Otis J; Rothman M
Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal follow-up of TTS-fentanyl use in patients with cancer-related pain: results of a compassionate-use study with special focus on elderly patients.
Menten J; Desmedt M; Lossignol D; Mullie A
Curr Med Res Opin; 2002; 18(8):488-98. PubMed ID: 12564660
[TBL] [Abstract][Full Text] [Related]
9. Inter- and intraindividual variabilities in pharmacokinetics of fentanyl after repeated 72-hour transdermal applications in cancer pain patients.
Solassol I; Bressolle F; Caumette L; Garcia F; Poujol S; Culine S; Pinguet F
Ther Drug Monit; 2005 Aug; 27(4):491-8. PubMed ID: 16044107
[TBL] [Abstract][Full Text] [Related]
10. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain.
Lorvidhaya V; Katanyoo K; Srisomboon J; Suprapaphorn P; Cheewakriangkrai C
J Med Assoc Thai; 2004 Mar; 87(3):319-25. PubMed ID: 15117050
[TBL] [Abstract][Full Text] [Related]
12. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
Portenoy RK; Payne R; Coluzzi P; Raschko JW; Lyss A; Busch MA; Frigerio V; Ingham J; Loseth DB; Nordbrock E; Rhiner M
Pain; 1999 Feb; 79(2-3):303-12. PubMed ID: 10068176
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.
Grond S; Radbruch L; Lehmann KA
Clin Pharmacokinet; 2000 Jan; 38(1):59-89. PubMed ID: 10668859
[TBL] [Abstract][Full Text] [Related]
14. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients.
Radbruch L; Sabatowski R; Petzke F; Brunsch-Radbruch A; Grond S; Lehmann KA
Palliat Med; 2001 Jul; 15(4):309-21. PubMed ID: 12054148
[TBL] [Abstract][Full Text] [Related]
15. Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine.
Vielvoye-Kerkmeer AP; Mattern C; Uitendaal MP
J Pain Symptom Manage; 2000 Mar; 19(3):185-92. PubMed ID: 10760623
[TBL] [Abstract][Full Text] [Related]
16. Transdermal fentanyl for severe cancer-related pain.
Yeo W; Lam KK; Chan AT; Leung TW; Nip SY; Johnson PJ
Palliat Med; 1997 May; 11(3):233-9. PubMed ID: 9205657
[TBL] [Abstract][Full Text] [Related]
17. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain.
Miyazaki T; Hanaoka K; Namiki A; Ogawa S; Kitajima T; Hosokawa T; Ishida T; Nogami S; Mashimo S
Clin Drug Investig; 2008; 28(5):313-25. PubMed ID: 18407717
[TBL] [Abstract][Full Text] [Related]
19. Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II, & III transfers.
Mystakidou K; Parpa E; Tsilika E; Katsouda E; Kouloulias V; Kouvaris J; Georgaki S; Vlahos L
J Pain; 2004 Mar; 5(2):119-32. PubMed ID: 15042520
[TBL] [Abstract][Full Text] [Related]
20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
